Bringing genomics to precision medicine for more personalised care

As noted at the global Healthcare Information and Management Systems Society (HIMSS) 2018 summit, precision medicine is entering the mainstream clinical workflow by facilitating better predictive care. This paradigm shift is enabled by the scientific and technological advances in the field of genomics leading to time and cost no longer constituting a barrier for precision medicine.

Tieto and BC Platforms have partnered to bring the benefits of genomics into predictive medicine. A new platform which combines genomics data and clinical data, provides new means for improving the quality of the diagnostic process. Tieto and BC Platform will do joint solution development and marketing leveraging BC platforms niche expertise together with Tieto’s strong position as an IT solution, integrator and service provider for the Nordic Health professionals.

Inge Andersson, Head of Product Portfolio and Offerings at Healthcare, Welfare and Education Nordic at Tieto, stated: “Genomic medicine is making a large impact to clinical care quality in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious diseases. Together with BC Platforms, we can empower our Lifecare solutions for Lab Information Management Systems (LIMS) and Electronic Medical Records (EMR) offerings to ensure that genomics data together with clinical data will be used to more accurately guide individual diagnoses and treatments, but also provide support of preventive and predictive medical decision making.”

Brett Villagrand, Head of Marketing at BC Platforms, added: ”Major Nordic Hospitals are very much at the forefront of deploying solutions to personalise their patients’ healthcare. The ability to process raw genome data in one platform to deliver actionable patient reports is a major advancement. Tieto is the largest healthcare specific system integrator in North Europe with a long history in healthcare, which makes them a great partner for us. BC Platforms wants to “democratise” the use of genomic data in both healthcare and Life Sciences. Partnerships like the one with Tieto will deliver on the promise of precision medicine.”